Healthcare · Industry
Biotechnology - List & Prices (656 stocks)
| Company | Ticker | Price | Mkt cap | P/E | Div yield |
|---|---|---|---|---|---|
| Wave Life Sciences, Inc. | WVE | $4.86 | $957.65M | — | |
| Design Therapeutics, Inc. | DSGN | $15.14 | $947.49M | — | |
| Olema Pharmaceuticals, Inc. | OLMA | $10.75 | $940.60M | — | |
| Annexon, Inc. | ANNX | $4.87 | $923.25M | — | |
| Rigel Pharmaceuticals, Inc. | RIGL | $48.67 | $909.15M | 2.9 | — |
| Aclaris Therapeutics, Inc. | ACRS | $6.17 | $908.22M | — | |
| Silence Therapeutics plc | SLN | $14.59 | $906.83M | — | |
| Cybin D/B/A Helus Pharma | HELP | $12.22 | $892.80M | — | |
| Climb Bio, Inc. | CLYM | $15.52 | $891.41M | — | |
| Theravance Biopharma, Inc. | TBPH | $17.08 | $886.77M | 16.4 | — |
| Achieve Life Sciences, Inc. | ACHV | $8.49 | $873.64M | — | |
| DBV Technologies S.A. | DBVT | $13.47 | $846.53M | — | |
| 4D Molecular Therapeutics, Inc. | FDMT | $14.97 | $827.01M | — | |
| CytomX Therapeutics, Inc. | CTMX | $3.71 | $808.41M | — | |
| ProKidney Corp. | PROK | $2.01 | $802.36M | — | |
| Nuvectis Pharma, Inc. | NVCT | $24.49 | $799.45M | — | |
| Pharming Group N.V. | PHAR | $11.23 | $794.84M | 80.2 | — |
| Monopar Therapeutics Inc. | MNPR | $117.56 | $789.08M | — | |
| Aura Biosciences, Inc. | AURA | $7.56 | $784.01M | — | |
| First Tracks Biotherapeutics Inc | TRAXV | $17.06 May 26, 2026 | $782.20M | — | — |
| AgomAb Therapeutics NV | AGMB | $15.78 | $777.13M | — | |
| Crescent Biopharma, Inc. | CBIO | $20.88 | $775.63M | — | |
| Neurogene Inc. | NGNE | $38.60 | $772.44M | — | |
| Phathom Pharmaceuticals, Inc. | PHAT | $9.50 | $768.56M | — | |
| Assembly Biosciences, Inc. | ASMB | $36.60 | $745.20M | 29.3 | — |
| Verastem, Inc. | VSTM | $8.20 | $742.62M | — | |
| Zevra Therapeutics, Inc. | ZVRA | $12.40 | $736.36M | 13.3 | — |
| Gyre Therapeutics, Inc. | GYRE | $6.86 | $727.39M | — | |
| BridgeBio Oncology Therapeutics, Inc. | BBOT | $8.98 | $719.96M | — | |
| Astria Therapeutics, Inc. | ATXS | $12.58 Jan 23, 2026 | $718.13M | — | |
| XOMA Royalty Corp | XOMA | $40.17 Jul 21, 2026 | $710.16M | 25.6 | — |
| Shattuck Labs, Inc. | STTK | $6.79 | $681.47M | — | |
| Allogene Therapeutics, Inc. | ALLO | $1.97 | $680.62M | — | |
| Sagimet Biosciences Inc. | SGMT | $10.94 | $680.02M | — | |
| Oculis Holding AG | OCS | $12.17 | $675.78M | — | |
| Prime Medicine, Inc. | PRME | $3.70 | $671.09M | — | |
| MiMedx Group, Inc. | MDXG | $4.57 | $666.13M | 114.3 | — |
| Altimmune, Inc. | ALT | $3.42 | $665.25M | — | |
| CorMedix Inc. | CRMD | $8.43 | $657.07M | 3.9 | — |
| Valneva SE | VALN | $6.89 | $653.33M | — | |
| BlossomHill Therapeutics, Inc. | BLSM | $22.01 | $640.08M | — | |
| Bright Minds Biosciences Inc. | DRUG | $65.16 | $639.35M | — | |
| MapLight Therapeutics, Inc. | MPLT | $13.77 | $638.62M | — | |
| OmniAb, Inc. | OABI | $4.33 | $629.54M | — | |
| Contineum Therapeutics, Inc. | CTNM | $16.70 | $628.27M | — | |
| Fennec Pharmaceuticals Inc. | FRX.TO | CA$17.42 | CA$610.87M | — | |
| Arvinas, Inc. | ARVN | $9.39 | $605.85M | 36.1 | — |
| Tectonic Therapeutic, Inc. | TECX | $30.75 | $601.14M | — | |
| Zura Bio Limited | ZURA | $6.23 | $597.02M | — | |
| Autolus Therapeutics plc | AUTL | $2.24 | $596.20M | — |
Wave Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $957.65M
- P/E
- unprofitable
Design Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $947.49M
- P/E
- unprofitable
Olema Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $940.60M
- P/E
- unprofitable
Annexon, Inc.
Healthcare / Biotechnology
- Market Cap
- $923.25M
- P/E
- unprofitable
Rigel Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $909.15M
- P/E
- 2.9
Aclaris Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $908.22M
- P/E
- unprofitable
Silence Therapeutics plc
Healthcare / Biotechnology
- Market Cap
- $906.83M
- P/E
- unprofitable
Cybin D/B/A Helus Pharma
Healthcare / Biotechnology
- Market Cap
- $892.80M
- P/E
- unprofitable
Climb Bio, Inc.
Healthcare / Biotechnology
- Market Cap
- $891.41M
- P/E
- unprofitable
Theravance Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $886.77M
- P/E
- 16.4
Achieve Life Sciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $873.64M
- P/E
- unprofitable
DBV Technologies S.A.
Healthcare / Biotechnology
- Market Cap
- $846.53M
- P/E
- unprofitable
4D Molecular Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $827.01M
- P/E
- unprofitable
CytomX Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $808.41M
- P/E
- unprofitable
ProKidney Corp.
Healthcare / Biotechnology
- Market Cap
- $802.36M
- P/E
- unprofitable
Nuvectis Pharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $799.45M
- P/E
- unprofitable
Pharming Group N.V.
Healthcare / Biotechnology
- Market Cap
- $794.84M
- P/E
- 80.2
Monopar Therapeutics Inc.
Healthcare / Biotechnology
- Market Cap
- $789.08M
- P/E
- unprofitable
Aura Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $784.01M
- P/E
- unprofitable
First Tracks Biotherapeutics Inc
Healthcare / Biotechnology
- Market Cap
- $782.20M
AgomAb Therapeutics NV
Healthcare / Biotechnology
- Market Cap
- $777.13M
- P/E
- unprofitable
Crescent Biopharma, Inc.
Healthcare / Biotechnology
- Market Cap
- $775.63M
- P/E
- unprofitable
Neurogene Inc.
Healthcare / Biotechnology
- Market Cap
- $772.44M
- P/E
- unprofitable
Phathom Pharmaceuticals, Inc.
Healthcare / Biotechnology
- Market Cap
- $768.56M
- P/E
- unprofitable
Assembly Biosciences, Inc.
Healthcare / Biotechnology
- Market Cap
- $745.20M
- P/E
- 29.3
Verastem, Inc.
Healthcare / Biotechnology
- Market Cap
- $742.62M
- P/E
- unprofitable
Zevra Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $736.36M
- P/E
- 13.3
Gyre Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $727.39M
- P/E
- unprofitable
BridgeBio Oncology Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $719.96M
- P/E
- unprofitable
Astria Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $718.13M
- P/E
- unprofitable
XOMA Royalty Corp
Healthcare / Biotechnology
- Market Cap
- $710.16M
- P/E
- 25.6
Shattuck Labs, Inc.
Healthcare / Biotechnology
- Market Cap
- $681.47M
- P/E
- unprofitable
Allogene Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $680.62M
- P/E
- unprofitable
Sagimet Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $680.02M
- P/E
- unprofitable
Oculis Holding AG
Healthcare / Biotechnology
- Market Cap
- $675.78M
- P/E
- unprofitable
Prime Medicine, Inc.
Healthcare / Biotechnology
- Market Cap
- $671.09M
- P/E
- unprofitable
MiMedx Group, Inc.
Healthcare / Biotechnology
- Market Cap
- $666.13M
- P/E
- 114.3
Altimmune, Inc.
Healthcare / Biotechnology
- Market Cap
- $665.25M
- P/E
- unprofitable
CorMedix Inc.
Healthcare / Biotechnology
- Market Cap
- $657.07M
- P/E
- 3.9
Valneva SE
Healthcare / Biotechnology
- Market Cap
- $653.33M
- P/E
- unprofitable
BlossomHill Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $640.08M
- P/E
- unprofitable
Bright Minds Biosciences Inc.
Healthcare / Biotechnology
- Market Cap
- $639.35M
- P/E
- unprofitable
MapLight Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $638.62M
- P/E
- unprofitable
OmniAb, Inc.
Healthcare / Biotechnology
- Market Cap
- $629.54M
- P/E
- unprofitable
Contineum Therapeutics, Inc.
Healthcare / Biotechnology
- Market Cap
- $628.27M
- P/E
- unprofitable
Fennec Pharmaceuticals Inc.
Healthcare / Biotechnology
- Market Cap
- CA$610.87M
- P/E
- unprofitable
Arvinas, Inc.
Healthcare / Biotechnology
- Market Cap
- $605.85M
- P/E
- 36.1
Tectonic Therapeutic, Inc.
Healthcare / Biotechnology
- Market Cap
- $601.14M
- P/E
- unprofitable
Zura Bio Limited
Healthcare / Biotechnology
- Market Cap
- $597.02M
- P/E
- unprofitable
Autolus Therapeutics plc
Healthcare / Biotechnology
- Market Cap
- $596.20M
- P/E
- unprofitable
Showing 201–250 of 656 · ranked by market capitalization
Where the trailing year was a loss, P/E appears as “unprofitable”; a dash is missing data.